SMG1P5: A Potential Drug Target for Cancer (G595101)

Target Name: SMG1P5

NCBI ID: G595101

SMG1P5

Other Name(s): SMG1 pseudogene 5

SMG1P5: A Potential Drug Target for Cancer

SMG1P5, also known as SMG1 pseudogene 5, is a gene that has been identified in various scientific studies as having potential as a drug target or biomarker. The gene is located on chromosome 12 and encodes a protein known as SMG1P5, which is a component of the superfamily A (SMG) of proteins that are characterized by the presence of a specific domain known as A.

SMG1P5 has been shown to play a role in various cellular processes, including cell adhesion, migration, and invasion. It is also involved in the regulation of various cellular processes that are important for the development and progression of cancer.

One of the key reasons why SMG1P5 has been identified as a potential drug target is its involvement in the regulation of cell adhesion. Adhesion is the process by which cells stick together to form tissues and organs. This process is critical for the development and maintenance of tissues and organs, and it is also involved in the regulation of various cellular processes that are important for cancer progression.

Studies have shown that SMG1P5 plays a role in the regulation of cell adhesion by promoting the stickiness of cells to various adhesion molecules. This is done through the interaction of SMG1P5 with adhesion molecules such as cadherins and integrins.

Another potential drug target for SMG1P5 is its role in the regulation of cell migration. Cell migration is the process by which cells move from their place of origin to their destination, and it is critical for the development and progression of cancer.

Studies have shown that SMG1P5 plays a role in the regulation of cell migration by promoting the migration of cells along the direction of the force that is acting on them. This is done through the interaction of SMG1P5 with factors that regulate cell migration, such as the protein known as FAK.

SMG1P5 is also involved in the regulation of the invasion of cancer cells. Invasion is the process by which cancer cells spread and form tumors in other parts of the body. This process is critical for the development and progression of cancer, and it is also influenced by the interactions between SMG1P5 and various proteins that regulate cell behavior.

Studies have shown that SMG1P5 plays a role in the regulation of cancer cell invasion by promoting the ability of cancer cells to stick to and invade the blood vessels that supply their tumors. This is done through the interaction of SMG1P5 with proteins known as vimentin and blindness.

In addition to its involvement in cell adhesion, migration, and invasion, SMG1P5 has also been shown to play a role in the regulation of various cellular processes that are important for the development and progression of cancer. For example, studies have shown that SMG1P5 plays a role in the regulation of cell apoptosis, which is the process by which cells die when they have reached a certain level of stress or damage.

In addition, SMG1P5 has also been shown to play a role in the regulation of angiogenesis, which is the process by which new blood vessels form in the body. This is done through the interaction of SMG1P5 with proteins known as PDGFR-尾 and FAK.

Overall, SMG1P5 has been identified as a potential drug target due to its involvement in the regulation of various cellular processes that are important for the development and progression of cancer. Further studies are needed to fully understand the role of SMG1P5 in these processes and to develop effective treatments for cancer.

Protein Name: SMG1 Pseudogene 5

The "SMG1P5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SMG1P5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets